Patient-driven consent-management tools and granular data segmentation need to be balanced for health equity, patient privacy and interoperability....
Regulations and ethics are imperative to ensure clinical trials are conducted in a way that protects patients while simultaneously helping to advance scientific research....
COVID-19 safety precautions have been rescinded as many try to to return to a sense of pre-pandemic normalcy. But the reality of disabled and immunocompromised people remains forgotten, causing them to feel left behind and further pushed out of society, disability advocates say....
Kristen Mahaffey discusses her career path and current role as Central Monitoring Service (CMS) Program Manager within the UW Clinical Research Office (CRO)....
The clinical trial industry must be proactive and transparent in its communications with underserved communities with less access to healthcare resources and a wariness about participating in medical research....
We need a new paradigm for increasing diversity in clinical trials....
Improving the use of technology in clinical trials is now a prime opportunity for the life sciences industry. With the right tools, sponsors can enhance the efficiency of trial execution, provide patients with new ways to participate in studies, and simplify collaboration with clinical sites....
We need to widen the data net and do a better job of analyzing those data to identify clinical trials participants from previously ignored patient populations....
Patients who participate in clinical trials win by benefiting from advancements discovered during previous trials as well as their own participation in successful studies. Doctors win by having more treatment options to offer their patients. Researchers win because clinical trials provide the opportunities they need...
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National Press Foundation Q&A....
English
Español
